Viewing nowRosuvastatin Tablet 10mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

MFDS item code 201607042 · Approved 2016.12.12 · Insurance code 665506910
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct therapy in patients with primary hypercholesterolemia and mixed hyperlipidemia when diet and exercise alone are insufficient. It is also used in conjunction with other therapies for patients with homozygous familial hypercholesterolemia to effectively lower blood cholesterol levels. By controlling total cholesterol and LDL-cholesterol levels to target values, it helps delay the progression of atherosclerosis. It can be safely used in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia when dietary measures are insufficient. Additionally, it is used as an adjunct to dietary therapy in patients with primary dysbetalipoproteinemia. This medication is utilized to reduce the risk of cardiovascular events such as stroke and myocardial infarction in patients with elevated high-sensitivity C-reactive protein levels and cardiovascular disease risk factors. Overall, this medication is effective in improving blood lipid levels and reducing cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administering doses greater than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in individuals who are allergic to any of the components. It should not be administered to patients with active liver disease or unexplained elevated liver enzyme levels. Patients with muscle disease or severe renal impairment should also avoid taking this medication. It should not be given to pregnant or breastfeeding women, or to women of childbearing potential who are not using effective contraception. Patients at high risk of muscle disease, such as those with moderate to severe renal impairment or hypothyroidism, should avoid high doses of this medication. Patients with genetic metabolic disorders such as lactose intolerance should not take this medication. This medication should be used with caution in individuals with a history of liver disease or those who consume excessive alcohol, and regular liver function tests are required. If symptoms of muscle pain or weakness occur, medical attention should be sought immediately for necessary testing. Individuals with reduced renal function or conditions such as hypothyroidism are at a greater risk of muscular adverse reactions, hence careful monitoring is necessary. This medication can rarely cause serious skin reactions, liver dysfunction, or muscle damage. If any adverse reactions occur, discontinue use and consult a healthcare professional immediately. Concomitant use with other drugs may increase blood concentration of this medication, raising the risk of muscle-related side effects. Therefore, any other medications being taken should be disclosed, especially since combination with fibrate drugs poses risks, and there may also be interactions with certain antiviral or antifungal medications. Pregnant or breastfeeding women should not take this medication, and women of childbearing potential should use appropriate contraception. In case of overdose, there is no specific antidote; symptom-based treatment is required, along with monitoring of liver function and muscle enzyme levels. Dizziness may occur during treatment; therefore, caution is advised when driving or operating machinery.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, severe myasthenia, cough, shortness of breath, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesic syndrome, memory impairment, confusion, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, fatigue, numbness, sensory disturbances, chest discomfort, anorexia, abdominal distension, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from exposure to air. The recommended storage temperature is between 1°C and 30°C at room temperature. Proper storage will help maintain the medication's efficacy.
Pink round film-coated tablets
30 tablets (15 tablets/PTP × 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.